S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ORMP Oramed Pharmaceuticals Inc

2.37

-0.03 (-1.25%)

Feb 18 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 13 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 11 February 2025 (1 week ago) • Edgar (US Regulatory)

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Tuesday 11 February 2025 (1 week ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

More Oramed Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions